Mirena® (Levonorgestrel intrauterine system): A successful novel drug delivery option in contraception

Susan Rose, Angela Chaudhari, C Matthew Peterson
Advanced drug delivery reviews · 2009 · vol. 61(10) , pp. 808–812 · doi:10.1016/j.addr.2009.04.022 · PMID:19445984 · W2138559341
review OA: closed CC0 ⤵ 6 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

This review explores the Mirena® levonorgestrel intrauterine system as a novel and successful drug delivery option for contraception.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Contraception Contraceptive Agents, Female Drug Delivery Systems Intrauterine Devices, Medicated Levonorgestrel Administration, Intravaginal Contraceptive Agents, Female Contraceptive Agents, Female Contraceptive Agents, Female Drug Administration Schedule Female Genital Diseases, Female Genital Diseases, Female Humans Levonorgestrel Levonorgestrel Levonorgestrel Menstruation Disturbances Menstruation Disturbances Patient Satisfaction

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (47)

Cited by (6)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:14:05.573375+00:00
License: CC0 · commercial use OK